Gapping up
In reaction to earnings/guidance:
- PVTL +4.8%, BTI +3%, CS +2.4% (provides FY18 guidance at investor day; approves CHF 1.5 bln ordinary share buyback) URI +1.6% (provided guidance from its Investor Day; will resume buybacks), .
M&A news:
- BILI +2.1% (to acquire major assets from NetEase (NTES) Comics)
Other news:
- BILI +2.1% (to acquire major assets from NetEase (NTES) Comics)
- LX +6.9% (expects limited impact from P2P regulations, raises loan origination guidance)
- HAIN +6.4% (disclosed the approval of the formalization of its Strategy Committee to evaluate strategic alternatives for the Company on Dec 5)
- ABB +4.1% (confirms that it is currently in discussions with Hitachi (HTHIY) to expand and re-define the existing strategic power grid partnership )
- AVEO +3.4% (enters into a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of AstraZeneca's IMFINZI in combination with FOTIVDA)
- APHA +2.4% (signs Letter of Intent with Insumos Medicos S.A. to enter into an exclusive supply and distribution agreement to provide medical cannabis in Paraguay)
- RARX +2.1% (prices offering of 8,387,097 shares of its common stock at $15.50 per share)
- PCRX +1.1% (publication of new data from a retrospective investigator-initiated study analyzing the use of EXPAREL)
- NEOS +1% (prices offering of 10,835,145 shares of common stock of the Company by GE Medical Systems Information Technologies)
- AAPL +1% (considering shifting iPhone production out of China if tariffs go to 25%, according to Bloomberg)
Analyst comments:
- CORT +6.3% (upgraded to Overweight from Neutral at Cantor Fitzgerald)
- VKTX +3.7% (initiated with a Buy at B. Riley FBR)
- LULU +2.7% (upgraded to Buy from Neutral at Citigroup)